T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes pill protect kidneys from failing?
Disease control Not yet recruitingThis study tests whether adding ganagliflozin tablets to standard care can slow the worsening of kidney disease in adults with type 2 diabetes and chronic kidney disease. About 1,244 participants will receive either the drug or a placebo for 120 weeks. The main goal is to see if …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New once-daily triple pill aims to simplify diabetes care in china
Disease control Not yet recruitingThis study tests a new once-daily pill that combines three diabetes drugs (henagliflozin, retagliptin, and metformin) in 300 Chinese adults with type 2 diabetes. The goal is to see how well it controls blood sugar and improves other health measures like weight and blood pressure …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug combo aims to reverse fatty liver damage in diabetics
Disease control Not yet recruitingThis study tests whether a drug called chiglitazar, combined with anti-inflammatory and liver-protecting treatments, can help people with both type 2 diabetes and a serious fatty liver disease called MASH. About 300 adults will receive either the combination or a placebo to see i…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC